{
  "id": 6831786,
  "title": "Candel Therapeutics CEO Tak sells $3.16m in CADL stock",
  "url": "https://urgent.news/2026/09/12/candel-therapeutics-ceo-tak-sells-3-16m-in-cadl-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-12T00:31:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/candel-therapeutics-ceo-tak-sells-316m-in-cadl-stock-93CH-4898579"
  },
  "original_language": "en",
  "account": "Candel Therapeutics CEO Paul Peter Tak recently sold $3.16 million worth of CADL stock over two days in September 2026. This comes as the stock has declined 17.5% in the past week but is up 120% over the last year. Tak sold 280,245 shares, ranging from $10.4564 to $11.4997 per share. The company carries a market cap of $867 million, which InvestingPro analysis indicates appears overvalued. Prior to selling, Tak purchased 125,000 shares in September 2020 through stock options. After these transactions, Tak directly owns 113,321 shares and 1,638,968 stock options. Candel Therapeutics is also launching a global Phase III trial for aglatimagene besadenovec to treat metastatic non-squamous non-small cell lung cancer, with an expected 150 site participation worldwide. Recent news includes Freedom Broker raising its price target to $15.00 and H.C. Wainwright maintaining a Buy rating with a $23.00 target.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Crowdstrike CEO George Kurtz sells $4.19m in company stock",
        "url": "https://urgent.news/2026/09/12/crowdstrike-ceo-george-kurtz-sells-4-19m-in-company-stock",
        "published": "2026-09-12T01:45:58.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}